Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06798961 · ClinicalTrials.gov registry record

Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)

A clinical trial of Cardiac Death and Cardiac Death, Sudden, sponsored by United States Naval Medical Center, San Diego.

Active
Registry status
1,000
Enrollment target
1
Study location

NCT06798961 is a study of Cardiac Death and Cardiac Death, Sudden that is active but no longer recruiting, run by United States Naval Medical Center, San Diego. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06798961, a study of Cardiac Death and Cardiac Death, Sudden, is active but no longer recruiting, sponsored by United States Naval Medical Center, San Diego.

ACTIVE NOT RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

The investigators propose a secondary chart review using EMR data to identify risk factors for sudden cardiac death in active-duty members diagnosed with an accessory pathway between the ages of 18-40.

Interventions

  • PROCEDURE Ablation
  • PROCEDURE Standard of care without ablation

Study Locations (1)

California

  • Naval Medical Center San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2024-11-01
Est. Completion 2025-12

What the Registry Record Tells You About NCT06798961

The ClinicalTrials.gov registry entry for NCT06798961 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Naval Medical Center, San Diego, which has 41 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cardiac Death appearing as the primary indexed condition, and to 2 interventions - of which Ablation is the first listed.

NCT06798961 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06798961 about?

NCT06798961 is a clinical study titled "Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)". The investigators propose a secondary chart review using EMR data to identify risk factors for sudden cardiac death in active-duty members diagnosed with an accessory pathway between the ages of 18-40.

What is the current status of trial NCT06798961?

This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2024-11-01. Estimated completion is 2025-12.

What conditions does trial NCT06798961 study?

This clinical trial studies the following conditions: Cardiac Death, Cardiac Death, Sudden, Wolf Parkinson White Syndrome.

What interventions are being tested in trial NCT06798961?

The interventions under investigation include: Ablation (PROCEDURE), Standard of care without ablation (PROCEDURE).

Who is sponsoring clinical trial NCT06798961?

This trial is sponsored by United States Naval Medical Center, San Diego, which has 41 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06798961 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.